COVID-19 Around the World: Impact on Rheumatology

Moderator(s)

• 

  Diane Kamen, MD, MSCR

  Medical University of South Carolina

Speaker(s)

• 

  Rebecca Grainger, PhD, FRACP, MBChB

  University of Otago
• 

  Jean Liew, MD

  Assistant Professor
  Boston University
  University of Washington

The COVID-19 pandemic has profoundly impacted the entire rheumatology community. Evidence-based insights into risk stratification and management guidelines are now emerging. In this session, current data from the COVID-19 Global Rheumatology Alliance Registry will be presented, including risk factors for poor patient outcomes, such as hospitalization, intubation and mortality. Additionally, this session will address the effect of immunomodulating and utilizing immunosuppressive medications on patient susceptibility to COVID-19 infection and on the COVID-19 clinical course.

Learning Objectives:

• Describe the incidence and distribution of COVID-19, particularly within rheumatic disease populations
• Recognize the risk factors for poor outcomes from COVID-19
• Discuss populations disproportionately vulnerable to COVID-19
• Describe management strategies for patients with rheumatic disease during the COVID-19 pandemic using a case-based approach

Presentations:

• 4:00 PM – 4:20 PM ET

  Lessons from the COVID-19 Global Rheumatology Registry: Epidemiology, Risk Factors & Outcomes
  Rebecca Grainger, PhD, FRACP, MBChB – University of Otago
• 4:20 PM – 4:40 PM ET

  Management of COVID-19 in Immunosuppressed Patients
  Jean W. Liew, MD – Boston University
• 4:40 PM – 5:00 PM ET

  Q&A